Stay updated on Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial
Sign up to get notified when there's something new on the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page.

Latest updates to the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry v3.6.5 has been added to the study's revision history. This updates the history to reflect the latest version label, replacing the previous v3.6.4 entry.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision entry (v3.6.4) was added to the study history, signaling a new version of the record. This appears to be a metadata update rather than a substantive change to study content.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page history now shows Revision: v3.6.3, replacing v3.6.2, indicating a newer build of the study record. This is a backend version update and does not affect the displayed study details or results.SummaryDifference0.1%

- Check43 days agoChange DetectedA new revision entry v3.6.2 was added to the history, and the older v3.6.0 entry was removed, updating the record's version history.SummaryDifference0.1%

- Check58 days agoChange DetectedThe record history now includes a 'No longer looking for participants' entry, indicating recruitment for the study has closed. It also adds a 'Revision: v3.6.0' entry and removes the previous 'Revision: v3.5.5', updating the version trail.SummaryDifference0.3%

- Check65 days agoChange DetectedRevision: v3.5.5 was added to the history, replacing the previous v3.5.4. It represents a minor update to the page's revision log rather than substantive changes.SummaryDifference0.1%

Stay in the know with updates to Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page.